Neuronetics Acquires Greenbrook TMS

Greenbrook TMS Acquires Success TMS (Check Five LLC)

July 14, 2022

Healthcare Services

Greenbrook TMS Inc. acquired Check Five LLC, doing business as Success TMS, through its wholly owned U.S. subsidiary TMS NeuroHealth Centers Inc. The transaction expands Greenbrook’s TMS treatment center footprint and adds a fast-growing provider with 47 active locations across Florida, Pennsylvania, Illinois, New Jersey, Nevada and Wisconsin. Concurrently, Greenbrook entered into a US$75 million secured credit facility with Madryn Asset Management to fund working capital and future expansion; the acquisition closed in early Q3 2022 (announced as closed).

Greenbrook TMS Acquires Achieve TMS East and Achieve TMS Central

October 1, 2021

Healthcare Services

Greenbrook TMS Inc. has completed the acquisition of Achieve TMS East, LLC and Achieve TMS Central, LLC, adding 17 treatment centers to its network. The initial aggregate purchase price was US$8.0 million (net of cash and debt) with a capped earn-out of up to US$2.5 million based on Achieve TMS East's performance over the subsequent 12 months.

Discovery Behavioral Health Acquires Dan Med TMS Neuro Institute

March 8, 2022

Healthcare Services

Discovery Behavioral Health, Inc. has acquired Dan Med TMS Neuro Institute, a specialized provider of transcranial magnetic stimulation (TMS) therapy that operates centers in the Seattle–Tacoma area (Bellevue, Kent, Renton) and Costa Mesa, California. The acquisition expands Discovery Behavioral Health's TMS capability and geographic footprint, improving access to treatment for patients with treatment‑resistant depression.

BioNTech Acquires Neon Therapeutics

January 16, 2020

Biotechnology

BioNTech SE will acquire Neon Therapeutics, Inc. in an all-stock transaction valued at approximately $67.0 million. Neon, a Cambridge-based developer of neoantigen-targeted T cell therapies, will become a wholly owned subsidiary of BioNTech to expand BioNTech’s T cell therapy capabilities and U.S. presence.

Bruker Corporation to Acquire Neurescence Inc.

November 12, 2022

Healthcare Services

Bruker Corporation has signed a definitive agreement to purchase 100% of the shares of Neurescence Inc., an ultralight fiber-bundle Multiscopes provider for simultaneous multi-region optical functional neuroimaging. The acquisition is expected to create synergies with Bruker’s multiphoton and head-mounted miniscope offerings, expanding its reach in freely behaving animal imaging and photostimulation.

Beacon Behavioral Partners Acquires The Neuropsychiatry & TMS Group

March 27, 2024

Healthcare Services

Beacon Behavioral Partners has acquired The Neuropsychiatry & TMS Group, an outpatient mental health provider in Tampa, Florida, marking Beacon's first partnership in Florida. The practice, led by Dr. Faizi Ahmed with three Tampa Bay locations and specializing in psychiatry and TMS treatment, will expand TMS services and grow its physician team with Beacon's support; Mertz Taggart provided sell-side advisory.